Compile Data Set for Download or QSAR

Found 1057 hits Enz. Inhib. hit(s) with Target = 'Free fatty acid receptor 2'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271161 (7-(2,3-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...) Show SMILES Cc1nc(N2CCOC(C)(C)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cccc(F)c1F Show InChI InChI=1S/C19H21F2N5O3S/c1-10-23-14-15(18(24-10)26-7-8-29-19(2,3)9-26)25-17(22)16(14)30(27,28)12-6-4-5-11(20)13(12)21/h4-6,25H,7-9,22H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271162 (7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...) Show SMILES COc1ccc(c(F)c1)S(=O)(=O)c1c(N)[nH]c2c(nc(C)nc12)N1CCO[C@@H](C1)C(F)(F)F Show InChI InChI=1/C19H19F4N5O4S/c1-9-25-14-15(18(26-9)28-5-6-32-13(8-28)19(21,22)23)27-17(24)16(14)33(29,30)12-4-3-10(31-2)7-11(12)20/h3-4,7,13,27H,5-6,8,24H2,1-2H3/t13-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271179 (7-(2-fluorobenzenesulfonyl)-N2-methyl-4-(2-methylm...) Show SMILES CNc1nc(N2CCOC(C)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H21FN6O3S/c1-10-9-25(7-8-28-10)17-14-13(23-18(21-2)24-17)15(16(20)22-14)29(26,27)12-6-4-3-5-11(12)19/h3-6,10,22H,7-9,20H2,1-2H3,(H,21,23,24)	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271169 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...) Show SMILES Cc1nc(N2CCO[C@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccc(F)cc1F Show InChI InChI=1/C18H16F5N5O3S/c1-8-25-13-14(17(26-8)28-4-5-31-12(7-28)18(21,22)23)27-16(24)15(13)32(29,30)11-3-2-9(19)6-10(11)20/h2-3,6,12,27H,4-5,7,24H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271163 (7-(4-chloro-2-fluorobenzenesulfonyl)-2-methyl-4-[(...) Show SMILES Cc1nc(N2CCO[C@@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccc(Cl)cc1F Show InChI InChI=1/C18H16ClF4N5O3S/c1-8-25-13-14(17(26-8)28-4-5-31-12(7-28)18(21,22)23)27-16(24)15(13)32(29,30)11-3-2-9(19)6-10(11)20/h2-3,6,12,27H,4-5,7,24H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271119 (7-(benzenesulfonyl)-4-(2-methylmorpholin-4-yl)-2-(...) Show SMILES CSc1nc(N2CCOC(C)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1 Show InChI InChI=1/C18H21N5O3S2/c1-11-10-23(8-9-26-11)17-14-13(21-18(22-17)27-2)15(16(19)20-14)28(24,25)12-6-4-3-5-7-12/h3-7,11,20H,8-10,19H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271121 (7-(benzenesulfonyl)-2-methyl-4-(propan-2-yloxy)-5H...) Show SMILES CC(C)Oc1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1S/C16H18N4O3S/c1-9(2)23-16-13-12(18-10(3)19-16)14(15(17)20-13)24(21,22)11-7-5-4-6-8-11/h4-9,20H,17H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271164 (7-(2,4-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) Show SMILES Cc1nc(N2CCO[C@@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccc(F)cc1F Show InChI InChI=1/C18H16F5N5O3S/c1-8-25-13-14(17(26-8)28-4-5-31-12(7-28)18(21,22)23)27-16(24)15(13)32(29,30)11-3-2-9(19)6-10(11)20/h2-3,6,12,27H,4-5,7,24H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271165 (7-(2,3-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) Show SMILES Cc1nc(N2CCO[C@@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cccc(F)c1F Show InChI InChI=1/C18H16F5N5O3S/c1-8-25-13-14(17(26-8)28-5-6-31-11(7-28)18(21,22)23)27-16(24)15(13)32(29,30)10-4-2-3-9(19)12(10)20/h2-4,11,27H,5-7,24H2,1H3/t11-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271170 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...) Show SMILES Cc1nc(N2CCO[C@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H17F4N5O3S/c1-9-24-13-14(17(25-9)27-6-7-30-12(8-27)18(20,21)22)26-16(23)15(13)31(28,29)11-5-3-2-4-10(11)19/h2-5,12,26H,6-8,23H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271115 (4-(2-methylmorpholin-4-yl)-7-(phenylsulfanyl)-5H-p...) Show SMILES CC1CN(CCO1)c1ncnc2c(Sc3ccccc3)c(N)[nH]c12 Show InChI InChI=1/C17H19N5OS/c1-11-9-22(7-8-23-11)17-14-13(19-10-20-17)15(16(18)21-14)24-12-5-3-2-4-6-12/h2-6,10-11,21H,7-9,18H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271177 (7-(4-chloro-2-fluorobenzenesulfonyl)-2-methyl-4-[(...) Show SMILES Cc1nc(N2CCO[C@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccc(Cl)cc1F Show InChI InChI=1/C18H16ClF4N5O3S/c1-8-25-13-14(17(26-8)28-4-5-31-12(7-28)18(21,22)23)27-16(24)15(13)32(29,30)11-3-2-9(19)6-10(11)20/h2-3,6,12,27H,4-5,7,24H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271182 (7-(2-fluorobenzenesulfonyl)-2-(methylsulfanyl)-4-[...) Show SMILES CSc1nc(N2CCOC(C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H17F4N5O3S2/c1-31-17-25-12-13(16(26-17)27-6-7-30-11(8-27)18(20,21)22)24-15(23)14(12)32(28,29)10-5-3-2-4-9(10)19/h2-5,11,24H,6-8,23H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271098 (7-(benzenesulfonyl)-4-[(2R,5R)-2,5-dimethylmorphol...) Show SMILES C[C@@H]1CN([C@H](C)CO1)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1/C19H23N5O3S/c1-11-10-27-12(2)9-24(11)19-16-15(21-13(3)22-19)17(18(20)23-16)28(25,26)14-7-5-4-6-8-14/h4-8,11-12,23H,9-10,20H2,1-3H3/t11-,12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271111 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[2-(trifluo...) Show SMILES Cc1nc(N2CCOC(C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H17F4N5O3S/c1-9-24-13-14(17(25-9)27-6-7-30-12(8-27)18(20,21)22)26-16(23)15(13)31(28,29)11-5-3-2-4-10(11)19/h2-5,12,26H,6-8,23H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271173 (7-(2,5-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) Show SMILES Cc1nc(N2CCO[C@@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cc(F)ccc1F Show InChI InChI=1/C18H16F5N5O3S/c1-8-25-13-14(17(26-8)28-4-5-31-12(7-28)18(21,22)23)27-16(24)15(13)32(29,30)11-6-9(19)2-3-10(11)20/h2-3,6,12,27H,4-5,7,24H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271146 (7-(3-fluorobenzenesulfonyl)-4-(2-methylmorpholin-4...) Show SMILES CC1CN(CCO1)c1nc(nc2c(c(N)[nH]c12)S(=O)(=O)c1cccc(F)c1)C(F)(F)F Show InChI InChI=1/C18H17F4N5O3S/c1-9-8-27(5-6-30-9)16-13-12(25-17(26-16)18(20,21)22)14(15(23)24-13)31(28,29)11-4-2-3-10(19)7-11/h2-4,7,9,24H,5-6,8,23H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271160 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2S)-2-(tr...) Show SMILES Cc1nc(N2CCO[C@@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H17F4N5O3S/c1-9-24-13-14(17(25-9)27-6-7-30-12(8-27)18(20,21)22)26-16(23)15(13)31(28,29)11-5-3-2-4-10(11)19/h2-5,12,26H,6-8,23H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271166 (7-(2,6-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...) Show SMILES Cc1nc(N2CCOC(C)(C)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1c(F)cccc1F Show InChI InChI=1S/C19H21F2N5O3S/c1-10-23-13-14(18(24-10)26-7-8-29-19(2,3)9-26)25-17(22)16(13)30(27,28)15-11(20)5-4-6-12(15)21/h4-6,25H,7-9,22H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271171 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...) Show SMILES Cc1nc(N2CCO[C@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cc(F)ccc1F Show InChI InChI=1/C18H16F5N5O3S/c1-8-25-13-14(17(26-8)28-4-5-31-12(7-28)18(21,22)23)27-16(24)15(13)32(29,30)11-6-9(19)2-3-10(11)20/h2-3,6,12,27H,4-5,7,24H2,1H3/t12-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271172 (7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...) Show SMILES COc1ccc(c(F)c1)S(=O)(=O)c1c(N)[nH]c2c(nc(C)nc12)N1CCO[C@H](C1)C(F)(F)F Show InChI InChI=1/C19H19F4N5O4S/c1-9-25-14-15(18(26-9)28-5-6-32-13(8-28)19(21,22)23)27-17(24)16(14)33(29,30)12-4-3-10(31-2)7-11(12)20/h3-4,7,13,27H,5-6,8,24H2,1-2H3/t13-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM270890 (7-(benzenesulfonyl)-4-(piperidin-1-yl)-5H-pyrrolo[...) Show SMILES Nc1[nH]c2c(ncnc2c1S(=O)(=O)c1ccccc1)N1CCCCC1 Show InChI InChI=1S/C17H19N5O2S/c18-16-15(25(23,24)12-7-3-1-4-8-12)13-14(21-16)17(20-11-19-13)22-9-5-2-6-10-22/h1,3-4,7-8,11,21H,2,5-6,9-10,18H2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271183 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[2-methyl-2...) Show SMILES Cc1nc(N2CCOC(C)(C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C19H19F4N5O3S/c1-10-25-13-14(17(26-10)28-7-8-31-18(2,9-28)19(21,22)23)27-16(24)15(13)32(29,30)12-6-4-3-5-11(12)20/h3-6,27H,7-9,24H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271088 (4-cyclopentyl-7-(3-fluorobenzenesulfonyl)-2-methyl...) Show SMILES Cc1nc(C2CCCC2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cccc(F)c1 Show InChI InChI=1S/C18H19FN4O2S/c1-10-21-14(11-5-2-3-6-11)15-16(22-10)17(18(20)23-15)26(24,25)13-8-4-7-12(19)9-13/h4,7-9,11,23H,2-3,5-6,20H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271112 (7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...) Show SMILES COc1ccc(c(F)c1)S(=O)(=O)c1c(N)[nH]c2c(nc(C)nc12)N1CCO[C@@H](C)C1 Show InChI InChI=1/C19H22FN5O4S/c1-10-9-25(6-7-29-10)19-16-15(22-11(2)23-19)17(18(21)24-16)30(26,27)14-5-4-12(28-3)8-13(14)20/h4-5,8,10,24H,6-7,9,21H2,1-3H3/t10-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271113 (4-[(2R,5R)-2,5-dimethylmorpholin-4-yl]-7-(2-fluoro...) Show SMILES C[C@@H]1CN([C@H](C)CO1)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C19H22FN5O3S/c1-10-9-28-11(2)8-25(10)19-16-15(22-12(3)23-19)17(18(21)24-16)29(26,27)14-7-5-4-6-13(14)20/h4-7,10-11,24H,8-9,21H2,1-3H3/t10-,11-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271175 (4-[(2,2-dimethyloxan-3-yl)oxy]-7-(2-fluorobenzenes...) Show SMILES Cc1nc(OC2CCCOC2(C)C)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C20H23FN4O4S/c1-11-23-15-16(19(24-11)29-14-9-6-10-28-20(14,2)3)25-18(22)17(15)30(26,27)13-8-5-4-7-12(13)21/h4-5,7-8,14,25H,6,9-10,22H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271147 (7-(2-fluoro-5-methoxybenzenesulfonyl)-2-methyl-4-(...) Show SMILES COc1ccc(F)c(c1)S(=O)(=O)c1c(N)[nH]c2c(nc(C)nc12)N1CCOC(C)C1 Show InChI InChI=1/C19H22FN5O4S/c1-10-9-25(6-7-29-10)19-16-15(22-11(2)23-19)17(18(21)24-16)30(26,27)14-8-12(28-3)4-5-13(14)20/h4-5,8,10,24H,6-7,9,21H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	4	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271077 (7-(benzenesulfonyl)-4-(2-ethylthiomorpholin-4-yl)-...) Show SMILES CCC1CN(CCS1)c1ncnc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1/C18H21N5O2S2/c1-2-12-10-23(8-9-26-12)18-15-14(20-11-21-18)16(17(19)22-15)27(24,25)13-6-4-3-5-7-13/h3-7,11-12,22H,2,8-10,19H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	4	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271174 (7-(2,6-Difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) Show SMILES Cc1nc(N2CCO[C@@H](C2)C(F)(F)F)c2[nH]c(N)c(c2n1)S(=O)(=O)c1c(F)cccc1F Show InChI InChI=1/C18H16F5N5O3S/c1-8-25-12-13(17(26-8)28-5-6-31-11(7-28)18(21,22)23)27-16(24)15(12)32(29,30)14-9(19)3-2-4-10(14)20/h2-4,11,27H,5-7,24H2,1H3/t11-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	4	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271159 (7-(4-chloro-2-fluorobenzenesulfonyl)-4-(2,2-dimeth...) Show SMILES Cc1nc(N2CCOC(C)(C)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccc(Cl)cc1F Show InChI InChI=1S/C19H21ClFN5O3S/c1-10-23-14-15(18(24-10)26-6-7-29-19(2,3)9-26)25-17(22)16(14)30(27,28)13-5-4-11(20)8-12(13)21/h4-5,8,25H,6-7,9,22H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	4	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271142 (7-(2,6-difluorobenzenesulfonyl)-2-methyl-4-(2-meth...) Show SMILES CC1CN(CCO1)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1c(F)cccc1F Show InChI InChI=1/C18H19F2N5O3S/c1-9-8-25(6-7-28-9)18-14-13(22-10(2)23-18)16(17(21)24-14)29(26,27)15-11(19)4-3-5-12(15)20/h3-5,9,24H,6-8,21H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	5	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271067 (7-(benzenesulfonyl)-4-N-ethyl-4-N-(oxan-4-ylmethyl...) Show SMILES CCN(CC1CCOCC1)c1ncnc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1S/C20H25N5O3S/c1-2-25(12-14-8-10-28-11-9-14)20-17-16(22-13-23-20)18(19(21)24-17)29(26,27)15-6-4-3-5-7-15/h3-7,13-14,24H,2,8-12,21H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	5	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271178 (7-(2-fluorobenzenesulfonyl)-4-[(2R)-2-(fluoromethy...) Show SMILES Cc1nc(N2CCO[C@@H](CF)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H19F2N5O3S/c1-10-22-14-15(18(23-10)25-6-7-28-11(8-19)9-25)24-17(21)16(14)29(26,27)13-5-3-2-4-12(13)20/h2-5,11,24H,6-9,21H2,1H3/t11-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	5	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271155 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(1,1,1-tri...) Show SMILES CC(Oc1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1F)C(F)(F)F Show InChI InChI=1/C16H14F4N4O3S/c1-7(16(18,19)20)27-15-12-11(22-8(2)23-15)13(14(21)24-12)28(25,26)10-6-4-3-5-9(10)17/h3-7,24H,21H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	5	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271143 (7-(2,4-difluorobenzenesulfonyl)-2-methyl-4-(2-meth...) Show SMILES CC1CN(CCO1)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccc(F)cc1F Show InChI InChI=1/C18H19F2N5O3S/c1-9-8-25(5-6-28-9)18-15-14(22-10(2)23-18)16(17(21)24-15)29(26,27)13-4-3-11(19)7-12(13)20/h3-4,7,9,24H,5-6,8,21H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271158 (3-(benzenesulfonyl)-7-(2,2-dimethylmorpholin-4-yl)...) Show SMILES CC1(C)CN(CCO1)c1ccnc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1S/C19H22N4O3S/c1-19(2)12-23(10-11-26-19)14-8-9-21-16-15(14)22-18(20)17(16)27(24,25)13-6-4-3-5-7-13/h3-9,22H,10-12,20H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271020 (7-(benzenesulfonyl)-4-[(2R,6S)-2,6-dimethylmorphol...) Show SMILES C[C@H]1CN(C[C@@H](C)O1)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1/C19H23N5O3S/c1-11-9-24(10-12(2)27-11)19-16-15(21-13(3)22-19)17(18(20)23-16)28(25,26)14-7-5-4-6-8-14/h4-8,11-12,23H,9-10,20H2,1-3H3/t11-,12+	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271097 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2S)-2-met...) Show SMILES C[C@H]1CN(CCO1)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1F Show InChI InChI=1/C18H20FN5O3S/c1-10-9-24(7-8-27-10)18-15-14(21-11(2)22-18)16(17(20)23-15)28(25,26)13-6-4-3-5-12(13)19/h3-6,10,23H,7-9,20H2,1-2H3/t10-/s2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271062 (4-(4,4-difluoropiperidin-1-yl)-7-(3-fluorobenzenes...) Show SMILES Cc1nc(N2CCC(F)(F)CC2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cccc(F)c1 Show InChI InChI=1S/C18H18F3N5O2S/c1-10-23-13-14(17(24-10)26-7-5-18(20,21)6-8-26)25-16(22)15(13)29(27,28)12-4-2-3-11(19)9-12/h2-4,9,25H,5-8,22H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271065 (7-(benzenesulfonyl)-4-[2-(propan-2-yl)morpholin-4-...) Show SMILES CC(C)C1CN(CCO1)c1ncnc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1/C19H23N5O3S/c1-12(2)14-10-24(8-9-27-14)19-16-15(21-11-22-19)17(18(20)23-16)28(25,26)13-6-4-3-5-7-13/h3-7,11-12,14,23H,8-10,20H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271057 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-{6-oxa-9-az...) Show SMILES Cc1nc(N2CCOC3(CCCC3)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1S/C21H24FN5O3S/c1-13-24-16-17(20(25-13)27-10-11-30-21(12-27)8-4-5-9-21)26-19(23)18(16)31(28,29)15-7-3-2-6-14(15)22/h2-3,6-7,26H,4-5,8-12,23H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271085 (US10059713, Example 206) Show SMILES CC1CN(CCO1)c1ncnc2c(c(N)[nH]c12)S(=O)(=O)C1CCN(CC1)C(=O)OCc1ccccc1 Show InChI InChI=1/C24H30N6O5S/c1-16-13-30(11-12-34-16)23-20-19(26-15-27-23)21(22(25)28-20)36(32,33)18-7-9-29(10-8-18)24(31)35-14-17-5-3-2-4-6-17/h2-6,15-16,18,28H,7-14,25H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	7	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271109 (7-(benzenesulfonyl)-4-(1-cyclopropylethoxy)-2-meth...) Show SMILES CC(Oc1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1)C1CC1 Show InChI InChI=1/C18H20N4O3S/c1-10(12-8-9-12)25-18-15-14(20-11(2)21-18)16(17(19)22-15)26(23,24)13-6-4-3-5-7-13/h3-7,10,12,22H,8-9,19H2,1-2H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	7	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271103 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-(prop-1-en-...) Show SMILES CC(=C)c1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1F Show InChI InChI=1S/C16H15FN4O2S/c1-8(2)12-13-14(20-9(3)19-12)15(16(18)21-13)24(22,23)11-7-5-4-6-10(11)17/h4-7,21H,1,18H2,2-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	7	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271117 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-{5-oxa-8-az...) Show SMILES Cc1nc(N2CCOC3(CCC3)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1ccccc1F Show InChI InChI=1S/C20H22FN5O3S/c1-12-23-15-16(19(24-12)26-9-10-29-20(11-26)7-4-8-20)25-18(22)17(15)30(27,28)14-6-3-2-5-13(14)21/h2-3,5-6,25H,4,7-11,22H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	8	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271151 (7-(2-fluorobenzenesulfonyl)-2-methyl-4-(propan-2-y...) Show SMILES CC(C)Oc1nc(C)nc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1F Show InChI InChI=1S/C16H17FN4O3S/c1-8(2)24-16-13-12(19-9(3)20-16)14(15(18)21-13)25(22,23)11-7-5-4-6-10(11)17/h4-8,21H,18H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	8	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271075 (7-(benzenesulfonyl)-4-(2-methylthiomorpholin-4-yl)...) Show SMILES CC1CN(CCS1)c1ncnc2c(c(N)[nH]c12)S(=O)(=O)c1ccccc1 Show InChI InChI=1/C17H19N5O2S2/c1-11-9-22(7-8-25-11)17-14-13(19-10-20-17)15(16(18)21-14)26(23,24)12-5-3-2-4-6-12/h2-6,10-11,21H,7-9,18H2,1H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	8	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271168 (7-(2,5-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...) Show SMILES Cc1nc(N2CCOC(C)(C)C2)c2[nH]c(N)c(c2n1)S(=O)(=O)c1cc(F)ccc1F Show InChI InChI=1S/C19H21F2N5O3S/c1-10-23-14-15(18(24-10)26-6-7-29-19(2,3)9-26)25-17(22)16(14)30(27,28)13-8-11(20)4-5-12(13)21/h4-5,8,25H,6-7,9,22H2,1-3H3	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	8	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair
Free fatty acid receptor 2 (Homo sapiens (Human))	BDBM271056 (US10059713, Example 175) Show SMILES Nc1[nH]c2c(OCC3CC3(F)F)ncnc2c1S(=O)(=O)c1ccccc1 Show InChI InChI=1/C16H14F2N4O3S/c17-16(18)6-9(16)7-25-15-12-11(20-8-21-15)13(14(19)22-12)26(23,24)10-4-2-1-3-5-10/h1-5,8-9,22H,6-7,19H2	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar	PC cid PC sid UniChem	Article US Patent	n/a	n/a	n/a	n/a	8	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Co., Ltd US Patent					Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10059713 (2018) Article DOI: 10.1021/jm970124v BindingDB Entry DOI: 10.7270/Q2251M7X
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1057 total )  |  Next  |  Last  >>

Jump to: